Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

被引：0

作者：

Lina Bollani

Eugenio Baraldi

Gaetano Chirico

Andrea Dotta

Marcello Lanari

Antonello Del Vecchio

Paolo Manzoni

Antonio Boldrini

Piermichele Paolillo

Sandra Di Fabio

Luigi Orfeo

Mauro Stronati

Costantino Romagnoli

机构：

[1] Unità di Neonatologia,Division of Neonatology, Department of Pediatrics

[2] Patologia Neonatale e Terapia Intensiva,undefined

[3] Policlinico S. Matteo,undefined

[4] U.O.C. Terapia Intensiva e patologia neonatale,undefined

[5] A.O. Padova,undefined

[6] U.O. C. Neonatologia e Terapia Intensiva neonatale,undefined

[7] A.O. Spedali civili,undefined

[8] U.O.C. Terapia intensiva neonatale,undefined

[9] Ospedale pediatrico Bambino Gesù,undefined

[10] U.O. Pediatria E Neonatologia ,undefined

[11] Ospedale Nuovo S. Maria della Scaletta,undefined

[12] U.O. Utin e Neonatologia,undefined

[13] Azienda Ospedaliera di Venere e Giovanni XXIII,undefined

[14] U.O. Neonatologia e TIN ospedaliera,undefined

[15] Azienda Ospedaliera OIRM-S. Anna,undefined

[16] U.O. Nido,undefined

[17] Patologia Neonatale e Terapia Intensiva Neonatale,undefined

[18] Ospedale Santa Chiara,undefined

[19] U.O. Divisione di Neonatologia,undefined

[20] Policlinico Caslino,undefined

[21] U.O. Neonatologia,undefined

[22] Presidio Ospedaliero S. Salvatore,undefined

[23] U.O. Nido,undefined

[24] Patologia Neonatale e Terapia Intensiva Neonatale,undefined

[25] Azienda Ospedaliera G. Rummo,undefined

[26] Unità di Neonatologia,undefined

[27] Patologia Neonatale e Terapia Intensiva,undefined

[28] Ospedale Policlinico S. Matteo,undefined

[29] U.O.C. Neonatologia,undefined

[30] Policlinico Universitario A. Gemelli,undefined

[31] Catholic University S.H.,undefined

来源：

Italian Journal of Pediatrics | / 41卷

关键词：

Respiratory Syncytial Virus; Down Syndrome; Bronchiolitis; Respiratory Syncytial Virus Infection; Esophageal Atresia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack of vaccines for RSV accentuate the role of prevention in decreasing the impact of this disease.

引用

共 50 条

[21] RESPIRATORY SYNCYTIAL VIRUS (RSV) PROPHYLAXIS IN SPECIAL POPULATIONS
Paes, B. A.
Li, A.
Lanctot, K. L.
Mitchell, I
[J]. VALUE IN HEALTH, 2011, 14 (07) : A398 - A399
[22] Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma
Igde, M.
Kabasakal, H.
Ozturk, O.
Karatekin, G.
Aygun, C.
[J]. ALLERGY, 2016, 71 : 534 - 534
[23] A 4-year survey on palivizumab respiratory syncytial virus (RSV)-prophylaxis: How can compliance be improved?
Pignotti, MS
Catarzi, S
Donzelli, G
[J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2006, 19 (04): : 221 - 224
[24] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
B. Paes
I. Mitchell
A. Li
K. L. Lanctôt
[J]. European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2703 - 2711
[25] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
Paes, B.
Mitchell, I.
Li, A.
Lanctot, K. L.
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (10) : 2703 - 2711
[26] Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab
Meissner, HC
Rennels, MB
Pickering, LK
Hall, CB
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (03) : 284 - 285
[27] Respiratory Syncytial Virus Prophylaxis with Palivizumab 2019 Update of the Recommendations of the Austrian Association of Pediatric and Adolescent Medicine
Resch, B.
Eber, E.
Ehringer-Schetitska, D.
Kiechl-Kohlendorfer, U.
Michel-Behnke, I.
Popow-Kraupp, T.
Redlberger-Fritz, M.
Seidel, M.
Strenger, V.
Wald, M.
Zacharasiewicz, A.
Berger, A.
[J]. PADIATRIE UND PADOLOGIE, 2019, 54 (06): : 270 - 276
[28] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
Scholz, H
[J]. ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122
[29] Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab
Wang, Daniel Y.
Saleem, Mahwesh
Paes, Bosco A.
Mitchell, Ian
Li, Abby
Lanctot, Krista L.
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (08) : 775 - 780
[30] Effectiveness of Palivizumab in Respiratory Syncytial Virus Prophylaxis in Children with Cystic Fibrosis
Winterstein, Almut G.
Eworuke, Efe
Xu, Dandan
Schuler, Pamela
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 148 - 148

← 1 2 3 4 5 →